EP0042
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EP0042, covering 2025-10-14 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of EP0042 [Phase 1, Phase 2]